BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Talvitie EM, Vilhonen H, Kurki S, Karlsson A, Orte K, Almangush A, Mohamed H, Liljeroos L, Singh Y, Leivo I, Laitinen T, Kallajoki M, Taimen P. High tumor mutation burden predicts favorable outcome among patients with aggressive histological subtypes of lung adenocarcinoma: A population-based single-institution study. Neoplasia 2020;22:333-42. [PMID: 32585428 DOI: 10.1016/j.neo.2020.05.004] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Al-Dherasi A, Liao Y, Al-Mosaib S, Hua R, Wang Y, Yu Y, Zhang Y, Zhang X, Jalayta R, Mousa H, Al-Danakh A, Alnadari F, Almoiliqy M, Baldi S, Shi L, Lv D, Li Z, Liu Q. Allele frequency deviation (AFD) as a new prognostic model to predict overall survival in lung adenocarcinoma (LUAD). Cancer Cell Int 2021;21:451. [PMID: 34446004 DOI: 10.1186/s12935-021-02127-z] [Reference Citation Analysis]
2 Sadhwani A, Chang HW, Behrooz A, Brown T, Auvigne-Flament I, Patel H, Findlater R, Velez V, Tan F, Tekiela K, Wulczyn E, Yi ES, Mermel CH, Hanks D, Chen PC, Kulig K, Batenchuk C, Steiner DF, Cimermancic P. Comparative analysis of machine learning approaches to classify tumor mutation burden in lung adenocarcinoma using histopathology images. Sci Rep 2021;11:16605. [PMID: 34400666 DOI: 10.1038/s41598-021-95747-4] [Reference Citation Analysis]
3 Chen C, Liu S, Jiang X, Huang L, Chen F, Wei X, Guo H, Shao Y, Li Y, Li W. Tumor mutation burden estimated by a 69-gene-panel is associated with overall survival in patients with diffuse large B-cell lymphoma. Exp Hematol Oncol 2021;10:20. [PMID: 33722306 DOI: 10.1186/s40164-021-00215-4] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
4 Gong L, He R, Xu Y, Luo T, Jin K, Yuan W, Zheng Z, Liu L, Liang Z, Li A, Zheng Z, Li H. Neoantigen load as a prognostic and predictive marker for stage II/III non-small cell lung cancer in Chinese patients. Thorac Cancer 2021;12:2170-81. [PMID: 34128337 DOI: 10.1111/1759-7714.14046] [Cited by in F6Publishing: 1] [Reference Citation Analysis]